Precise medicine is the target for medical development and covers
the whole process from diagnosis, treatment and prevention. The
final goal is to achieve precise health, experts told the
International Forum on Innovation and Emerging Industries
Development launched in Shanghai Jiao Tong University’s School of
Medicine.
Experts from home and abroad discussed the new theory and
technology on biological science, big data and medical use of
artificial intelligence, cancer immunology and genetics and
molecular biology in an effort to boost the adoption and
communication of cutting-edge technologies in the health and
pharmaceutical field.
Pirjo Nuutila from University of Turku in Finland said Finnish
government started to establish database 10 years ago through
collecting information of genome, which is responsible for 40
percent of a person‘ health, digital medical record from hospitals
and pharmacies and personal health data including public sports and
diet habit. All information in the database is used for health care
and to achieve precise medicine.
Katrin Rupalla from Bristol-Myers Squibb said drug development
should target different spectrum of diseases in different regions.
For instance, the incidence of nasopharynx cancer in southern
China is higher than the northern regions. Pharmaceutical companies
can develop drugs in line with different regions. Different
spectrum of diseases can indicate different diseases in local
population and allows companies to do more targeted research and
development, he said.
原文鏈接：https://www.shine.cn/news/metro/1809232631/?from=singlemessage&isappinstalled=0
